Articles On Compumedics (ASX:CMP)

Title Source Codes Date
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead CMP 1 month ago
Hot Money Monday: This is what the Father of Momentum Investing thought about ‘undervalued’ stocks

Momentum investing has been shown to be a successful strategy over the long term. The strategy essentially involves “buying high, but hoping to sell even higher” – which is the counter to the well known strategy of “buy low and sell high”....

Stockhead CMP 1 month ago
Hot Money Monday: ASX is best place in the world to profit from momentum strategy, says this fundie

A momentum trader will essentially be “buying high, but hoping to sell even higher” – which is the counter to the well known strategy of “buy low and sell high”. The biggest question for momentum traders is therefore how to find those stock...

Stockhead CMP 1 month ago
Closing Bell: ASX ends it like Beckham… lower and with a pretty whimper, which could still suggest good things ahead

The ASX benchmark has closed slightly lower on Friday Losses across the Energy Sector weighed Small caps led ID8   The Aussie sharemarket has ended lower on Friday, driven to a small disgrace by the ongoing declines in oil prices – down...

Stockhead CMP 4 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead CMP 4 months ago
Closing Bell: Australian stocks go higher, for longer on bets The Fed won’t have to

The ASX has ended Wednesday jumping almost 100 points. Huge effort, everyone Energy Sector misses out on all the positive vibes Small caps led by Findi and Firebrick Pharma   The Australian sharemarket is in fine fettle on this Wednesday...

Stockhead CMP 4 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead CMP 5 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead CMP 6 months ago
CLOSING BELL: ASX sinks to -1.4pc, despite a late tech rally and some sunny Small Caps news

Benchmark slides throughout the day after a shocker on Wall Street last night. Utilities did best but still ended up losing, down 0.3% for the day. Paincheck a ray of sunshine this afternoon, up 33% today despite an early speeding ticket....

Stockhead CMP 6 months ago
Closing Bell: Local markets shed 0.6pc as we brace for tonight’s US Fed call

The ASX 200 benchmark falls 0.6% as we brace for news from The Fed Sector losses led by Resources, while Consumers make gains Small caps led by Alderan, and BNPL Sezzle returns   Local markets made it a hat trick of losses, with the re...

Stockhead CMP 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead CMP 6 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead CMP 6 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead CMP 6 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead CMP 7 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead CMP 7 months ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead CMP 9 months ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead CMP 9 months ago
ASX Biotech Winners in May: We’re finally seeing signs of life on the back of another clinical breakthrough

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

Stockhead CMP 9 months ago
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

Stockhead CMP 10 months ago
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

Stockhead CMP 10 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead CMP 10 months ago
Top 10 at 10: These ASX seafood, copper and rare earths stocks are getting snapped up in early trade

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead CMP 1 year ago
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Stockhead CMP 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead CMP 1 year ago
Closing Bell: ASX drops 0.41%, RBA predicts more interest rate rises next year

ASX 200 down 0.41% on lower than normal volume  Small cap index falls 1.17% and 7 out 11 sectors finish lower RBA raises the cash rate by 25 basis points to 3%   The ASX200 was down 0.41% today. The ASX Emerging Companies (XEC) index was...

Stockhead CMP 1 year ago
How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Stockhead CMP 1 year ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead CMP 1 year ago
Market Highlights: US inflation and 5 ASX small caps to watch on Thursday

US inflation is at the highest level in 41 years Wall Street was down, but didn’t react strongly to the data The ASX is set to open flattish US CPI delivered another shock as the latest release showed that headline inflation rose by 9.1%...

Stockhead CMP 1 year ago
Closing Bell: Volatile? The ASX 200 has criss-crossed its opening level for the 17th time today. (So that’s a yes)

The ASX 200 ends ever so slightly up, XEC finds 0.4% Gains in consumer discretionary, tech offset big losses for energy, resources, materials. South Korea, Kiwi’s lift rates ahead of tonight’s US CPI read Investors are facing crunch time...

Stockhead CMP 1 year ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead CMP 1 year ago
Closing Bell: Galileo digging all the right holes today; big miners, not so much

Both ASX Small Cap and benchmark index are down about 0.5% A bleak forecast from Covid-stricken China hits resources stocks Appen in trading halt after jumping 30%     Local markets took a turn for the worse on Thursday after Chinese Prem...

Stockhead CMP 1 year ago
Closing Bell: Tech on sale as risk assets start to look a lot like riskier assets

Aussie small cap index falls flat, day two The ASX200 up 0.65% Conico is 50% higher   Rising gold prices and teetering tech stocks are playing dice for the soul of the ASX Emerging Companies (XEC) index on Wednesday, as the small cap top...

Stockhead CMP 1 year ago
Closing Bell: Local markets cope pretty well with Wall Street bleed

Aussie small cap index falls 1.4% The ASX200 down 1.65% Thursday is Arafura Day!   Down less than 2% and I think we can call that a win. No one likes the sight of blood and after the major Wall Street indices shed more than 3.5% a piece,...

Stockhead CMP 1 year ago
Check Up: Money managers are still bullish on Healthcare; here’s what they said

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Stockhead CMP 1 year ago
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Stockhead CMP 1 year ago
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Stockhead CMP 1 year ago
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead CMP 2 years ago
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Stockhead CMP 2 years ago
ASX Tech Stocks: Data3 gains on results forecast, while resignations & appointments mark the new year

The share price in software company Data#3 Limited (ASX:DTL) has risen around ~12% in morning trade to $6.50 after it said its FY22 results are expected to be better than forecast. Profit up Net profit before tax (NPBT) for the first half...

Stockhead CMP 2 years ago
Closing Bell: Gains across the small cap space as the ASX edges higher

The ASX edged higher in a fairly directionless session in Thursday trade, after US markets comfortably digested the latest round of inflation data overnight. The iron ore majors led the way with strong demand across the board, with more mut...

Stockhead CMP 2 years ago
ASX Health Stocks: Immuron up 29pc on $6.2m travellers’ diarrhoea clinical study for US military

Immuron nabs $6.2m clinical research deal for US Military strength Travelan dose ECS Botanics reports record revenue of $1.5m expected for Q2 FY22 Compumedics secures first major magnetoencephalography (MEG) sale in China Immuron (ASX:IMC...

Stockhead CMP 2 years ago
Compumedics secures record sale orders for first half of financial year, inks second MEG sale to Tianjin Normal University

Compumedics has begun the new calendar year with strong sales growth up 33% from the same period last year and a second MEG sale to Tianjin Normal University in China to the tune of $4.2 million.

Proactive Investors CMP 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Wednesday

US markets were more buoyant overnight, after Federal Reserve Chairman Jerome Powell provided some extra context around the bank’s policy tightening plans. In testimony to Congress, Powell reiterated the Fed will end its asset purchase prog...

Stockhead CMP 2 years ago
Closing Bell: ASX limps into the close while a post-COVID ‘meme stonk’ roars higher

It was a lacklustre session for local stocks in Tuesday trade, as the ASX 200 limped into the close with a fall of 0.77% while the microcap Emerging Companies index traded flat. In an environment of rising bond yields, the broader tone is s...

Stockhead CMP 2 years ago
Closing Bell: ASX treads water while an IPO dips on debut

Local stocks made a cautious start to the week, following a fairly volatile trading period last week as jitters stemming from rising bond yields dimmed risk sentiment on global markets. The ASX 200 opened in the red before clawing back some...

Stockhead CMP 2 years ago
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Stockhead CMP 2 years ago
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Stockhead CMP 2 years ago
Compumedics creates local jobs with wearable medtech device

Proactive Investors CMP 2 years ago
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Stockhead CMP 2 years ago
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Stockhead CMP 2 years ago